Summary data on proposals submitted to the RADx Tech and ATP Programs.
- 960 million tests produced
- 100 companies supported
- 35 FDA authorizations
RADx Tech Timeline
See the milestones and success that have unfolded since the beginning of the RADx Tech program.
The RADx Tech and ATP programs leverage the Point of Care Technology Research Network and joined with numerous other federal agencies, offices, NIH institutes, and contractors.
Tests in Development
Descriptions of innovative point of care, home-based, improved clinical laboratory tests, and testing products that are increasing the capacity of testing in the U.S.
Learn more about this accelerated pathway designed to help bring to market over the counter diagnostic tests for COVID-19 that are not yet authorized by the FDA.
When to Test tool now has an individual calculator to help guide individuals and families on COVID-19 testing. The Testing Impact Calculator also includes tools to help organizations plan for and develop testing strategies, and playbooks for pooled testing and K-12 schools. This site includes other resources on testing strategies and obtaining supplies. Try the calculator.
The Say Yes COVID Test project is a cooperative effort from state and local health departments, NIH, and CDC. This program offers access to free, rapid, at-home COVID-19 testing in select communities throughout the U.S. Learn more.
Information about studies to evaluate diagnostic tests being developed for COVID-19.
This webinar series hosted by POCTRN provides information on RADx® Tech/ATP program activities. Register for upcoming events or watch previous webinars.
View videos about RADx Tech/ATP programs, interviews with the NIBIB Director and more.